longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Blossomhill Therapeutics

BLSM

26.1150.51% ( -0.135 )
Trading: Sep 17, 10:56:29 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Blossomhill Therapeutics (BLSM)

BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. It...

Open
26.490
High
27.800
Low
25.700
Prev. Close
26.250
Volume
45.57K
Turnover
1.22M
Avg Price
26.685
Bid/Ask Ratio
85.19%
Amplitude
8.00%
52wk High
27.800
Volume Ratio
0.00
Turnover Ratio
0.27%
52wk Low
15.250
Float Mkt Cap
433.61M
Market CapUSD
800.26M
P/ETTM
Loss
P/EDynamic
Loss
P/EStatic
--
EPSTTM
-2.32
EPSDynamic
-2.74
EPSStatic
--
BVPS
-4.96
P/B
--
Circulating Supply
16.60M
Dividend YieldTTM
--
DividendTTM
--
Shares
30.64M
Min lot size
1
Currency
USD

Blossomhill Therapeutics Analyst Rating

View more

Forecast & Rating

Sep 15, 2026
Price forecast
$32.2023.30%
Forecast & RatingStrong buy
5analysts
  • Strong buy80.00%
  • Buy20.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%
Strong buy
4
Buy
1
Hold
0
Sell
0
Strong sell
0